Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot"
<p>Abstract</p> <p>The assessment of cellular anti-viral immunity is often hampered by the limited availability of adequate samples, especially when attempting simultaneous, high-resolution determination of T cell responses against multiple viral infections. Thus, the development o...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2005-05-01
|
| Series: | Journal of Translational Medicine |
| Subjects: | |
| Online Access: | http://www.translational-medicine.com/content/3/1/20 |
| _version_ | 1818515621208391680 |
|---|---|
| author | Wong Johnson T Suscovich Todd J Linde Caitlyn Henry Leah M Hewitt Hannah S Chisholm John V Loggi Elisabetta Bihl Florian K Frahm Nicole Andreone Pietro Brander Christian |
| author_facet | Wong Johnson T Suscovich Todd J Linde Caitlyn Henry Leah M Hewitt Hannah S Chisholm John V Loggi Elisabetta Bihl Florian K Frahm Nicole Andreone Pietro Brander Christian |
| author_sort | Wong Johnson T |
| collection | DOAJ |
| description | <p>Abstract</p> <p>The assessment of cellular anti-viral immunity is often hampered by the limited availability of adequate samples, especially when attempting simultaneous, high-resolution determination of T cell responses against multiple viral infections. Thus, the development of assay systems, which optimize cell usage, while still allowing for the detailed determination of breadth and magnitude of virus-specific cytotoxic T lymphocyte (CTL) responses, is urgently needed. This study provides an up-to-date listing of currently known, well-defined viral CTL epitopes for HIV, EBV, CMV, HCV and HBV and describes an approach that overcomes some of the above limitations through the use of peptide matrices of optimally defined viral CTL epitopes in combination with anti-CD3 in vitro T cell expansion and re-use of cells from negative ELISpot wells. The data show that, when compared to direct ex vivo cell preparations, antigen-unspecific in vitro T cell expansion maintains the breadth of detectable T cell responses and demonstrates that harvesting cells from negative ELISpot wells for re-use in subsequent ELISpot assays (RecycleSpot), further maximized the use of available cells. Furthermore when combining T cell expansion and RecycleSpot with the use of rationally designed peptide matrices, antiviral immunity against more than 400 different CTL epitopes from five different viruses can be reproducibly assessed from samples of less than 10 milliliters of blood without compromising information on the breadth and magnitude of these responses. Together, these data support an approach that facilitates the assessment of cellular immunity against multiple viral co-infections in settings where sample availability is severely limited.</p> |
| first_indexed | 2024-12-11T00:31:11Z |
| format | Article |
| id | doaj.art-2c257072fc974410a06b1c0390eae7d0 |
| institution | Directory Open Access Journal |
| issn | 1479-5876 |
| language | English |
| last_indexed | 2024-12-11T00:31:11Z |
| publishDate | 2005-05-01 |
| publisher | BMC |
| record_format | Article |
| series | Journal of Translational Medicine |
| spelling | doaj.art-2c257072fc974410a06b1c0390eae7d02022-12-22T01:27:20ZengBMCJournal of Translational Medicine1479-58762005-05-01312010.1186/1479-5876-3-20Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot"Wong Johnson TSuscovich Todd JLinde CaitlynHenry Leah MHewitt Hannah SChisholm John VLoggi ElisabettaBihl Florian KFrahm NicoleAndreone PietroBrander Christian<p>Abstract</p> <p>The assessment of cellular anti-viral immunity is often hampered by the limited availability of adequate samples, especially when attempting simultaneous, high-resolution determination of T cell responses against multiple viral infections. Thus, the development of assay systems, which optimize cell usage, while still allowing for the detailed determination of breadth and magnitude of virus-specific cytotoxic T lymphocyte (CTL) responses, is urgently needed. This study provides an up-to-date listing of currently known, well-defined viral CTL epitopes for HIV, EBV, CMV, HCV and HBV and describes an approach that overcomes some of the above limitations through the use of peptide matrices of optimally defined viral CTL epitopes in combination with anti-CD3 in vitro T cell expansion and re-use of cells from negative ELISpot wells. The data show that, when compared to direct ex vivo cell preparations, antigen-unspecific in vitro T cell expansion maintains the breadth of detectable T cell responses and demonstrates that harvesting cells from negative ELISpot wells for re-use in subsequent ELISpot assays (RecycleSpot), further maximized the use of available cells. Furthermore when combining T cell expansion and RecycleSpot with the use of rationally designed peptide matrices, antiviral immunity against more than 400 different CTL epitopes from five different viruses can be reproducibly assessed from samples of less than 10 milliliters of blood without compromising information on the breadth and magnitude of these responses. Together, these data support an approach that facilitates the assessment of cellular immunity against multiple viral co-infections in settings where sample availability is severely limited.</p>http://www.translational-medicine.com/content/3/1/20Cytotoxic T CellsHIVEBVCMVHCVHBVCTLepitopepeptidecell expansionanti-CD3ELISpotpeptide matrix |
| spellingShingle | Wong Johnson T Suscovich Todd J Linde Caitlyn Henry Leah M Hewitt Hannah S Chisholm John V Loggi Elisabetta Bihl Florian K Frahm Nicole Andreone Pietro Brander Christian Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot" Journal of Translational Medicine Cytotoxic T Cells HIV EBV CMV HCV HBV CTL epitope peptide cell expansion anti-CD3 ELISpot peptide matrix |
| title | Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot" |
| title_full | Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot" |
| title_fullStr | Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot" |
| title_full_unstemmed | Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot" |
| title_short | Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot" |
| title_sort | simultaneous assessment of cytotoxic t lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices anti cd3 mab t cell expansion and recyclespot |
| topic | Cytotoxic T Cells HIV EBV CMV HCV HBV CTL epitope peptide cell expansion anti-CD3 ELISpot peptide matrix |
| url | http://www.translational-medicine.com/content/3/1/20 |
| work_keys_str_mv | AT wongjohnsont simultaneousassessmentofcytotoxictlymphocyteresponsesagainstmultipleviralinfectionsbycombinedusageofoptimalepitopematricesanticd3mabtcellexpansionandrecyclespot AT suscovichtoddj simultaneousassessmentofcytotoxictlymphocyteresponsesagainstmultipleviralinfectionsbycombinedusageofoptimalepitopematricesanticd3mabtcellexpansionandrecyclespot AT lindecaitlyn simultaneousassessmentofcytotoxictlymphocyteresponsesagainstmultipleviralinfectionsbycombinedusageofoptimalepitopematricesanticd3mabtcellexpansionandrecyclespot AT henryleahm simultaneousassessmentofcytotoxictlymphocyteresponsesagainstmultipleviralinfectionsbycombinedusageofoptimalepitopematricesanticd3mabtcellexpansionandrecyclespot AT hewitthannahs simultaneousassessmentofcytotoxictlymphocyteresponsesagainstmultipleviralinfectionsbycombinedusageofoptimalepitopematricesanticd3mabtcellexpansionandrecyclespot AT chisholmjohnv simultaneousassessmentofcytotoxictlymphocyteresponsesagainstmultipleviralinfectionsbycombinedusageofoptimalepitopematricesanticd3mabtcellexpansionandrecyclespot AT loggielisabetta simultaneousassessmentofcytotoxictlymphocyteresponsesagainstmultipleviralinfectionsbycombinedusageofoptimalepitopematricesanticd3mabtcellexpansionandrecyclespot AT bihlfloriank simultaneousassessmentofcytotoxictlymphocyteresponsesagainstmultipleviralinfectionsbycombinedusageofoptimalepitopematricesanticd3mabtcellexpansionandrecyclespot AT frahmnicole simultaneousassessmentofcytotoxictlymphocyteresponsesagainstmultipleviralinfectionsbycombinedusageofoptimalepitopematricesanticd3mabtcellexpansionandrecyclespot AT andreonepietro simultaneousassessmentofcytotoxictlymphocyteresponsesagainstmultipleviralinfectionsbycombinedusageofoptimalepitopematricesanticd3mabtcellexpansionandrecyclespot AT branderchristian simultaneousassessmentofcytotoxictlymphocyteresponsesagainstmultipleviralinfectionsbycombinedusageofoptimalepitopematricesanticd3mabtcellexpansionandrecyclespot |